On Tuesday, Eaton Corp plc(NYSE:ETN)’s shares inclined 2.96% to $56.68.
Power administration company Eaton Corporation plc (ETN) declared that operating earnings per share, which exclude charges of $0.02 per share to integrate recent acquisitions, were $1.16 for the second quarter of 2015, up 5 percent over the second quarter of 2014, adjusted for the Aerospace divestitures and the litigation settlements recorded in the second quarter of 2014. Sales in the second quarter of 2015 were $5.4 billion, 7 percent lower than the same period in 2014. Operating earnings for the second quarter of 2015, not taking into account pre-tax charges of $12 million to integrate recent acquisitions, were $543 million.
Eaton Corporation plc operates as a power administration company worldwide. Its Electrical Products segment offers electrical components, industrial components, residential products, wiring devices, and structural support systems, in addition to single phase power quality, emergency lighting, fire detection, circuit protection, and lighting products. The company’s Electrical Systems and Services segment provides power distribution and assemblies, three phase power quality products, hazardous duty electrical equipment, intrinsically safe explosion-proof instrumentation, utility power distribution products, power reliability equipment, and services.
Anthem Inc(NYSE:ANTM)’s shares gained 3.62% to $146.55.
A.M. Best has upgraded the financial strength rating to A- (Excellent) from B++ (Good) and the issuer credit rating to “a-” from “bbb” of Sterling Life Insurance Company (Sterling) (Chicago, IL). Additionally, A.M. Best has revised the under review implications status on the ratings to developing from positive.
The rating action follows the accomplished acquisition of Sterling by Cigna Corporation (Cigna) [NYSE:CI]. Sterling should benefit from Cigna’s financial strength and parental support if needed. The acquisition of Sterling fits Cigna’s strategy to further enhance the scale of its Medicare supplement business. The ratings of all Cigna’s auxiliaries remain under review with developing implication following the declarement of Cigna’s acquisition by Anthem, Inc. (Anthem) [NYSE:ANTM]. That acquisition is subject to multiple regulatory approvals and is predictable to close in late 2016.
Anthem, Inc., through its auxiliaries, operates as a health benefits company in the United States. It operates through three segments: Commercial and Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small employer, individual, Medicaid, and senior markets.
At the end of Tuesday’s trade, Horizon Pharma PLC(NASDAQ:HZNP)‘s shares surged 1.09% to $29.72.
Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, recently declared it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. patent application number 14/705,606 (U.S. publication number 2015-0231262), entitled “Diclofenac Topical Formulation” that covers Horizon’s U.S. approved product PENNSAID® (diclofenac sodium topical solution) 2% w/w (PENNSAID 2%).
This Notice of Allowance concludes the substantive examination of the patent application and will result in the issuance of a U.S. patent after administrative processes are accomplished. The U.S. patent planned to issue from this application will expire October 17, 2027. After issuance, Horizon plans to list the patent in the FDA’s Approved Drug Products with Therapeutic Equivalence Evaluations, or Orange Book.
Horizon Pharma plc, a specialty biopharmaceutical company, engages in identifying, developing, acquiring or in-licensing, and commercializing medicines for the treatment of arthritis, pain, inflammatory, and/or orphan diseases in the United States and internationally. The company offers ACTIMMUNE for reducing the frequency and severity of serious infections associated with chronic granulomatous disease; DUEXIS, a proprietary tablet formulation for the relief of signs and symptoms of rheumatoid arthritis (RA) and osteoarthritis (OA), and to decrease the risk of developing upper gastrointestinal ulcers in patients who are taking ibuprofen for these indications; PENNSAID for the treatment of pain of OA of the knee; and VIMOVO, a proprietary fixed-dose multi-layer delayed-release tablet for the relief of the signs and symptoms of OA, RA, and ankylosing spondylitis (AS).
Citrix Systems, Inc.(NASDAQ:CTXS), ended its Tuesday’s trading session with 2.87% gain, and closed at $69.84.
For VMware customers under pressure to improve their app and desktop experience, gain greater infrastructure flexibility and simplify end user computing administration, Citrix is introducing a free cloud-based service to migrate VMware Horizon View virtual app and desktop deployments to XenApp and XenDesktop. Powered by the new Citrix Lifecycle Administration Service – now accessible from Citrix Operatespace Cloud – the new service enables administrators to do an in-place migration in less than 15 minutes by easily exporting application and desktop settings from Horizon View into the Citrix app and desktop delivery solution. The creation of the migration service addresses numerous requests Citrix has received to salvage failed, stalled and small VMware VDI deployments.
The free migration service dramatically simplifies and accelerates the migration process, providing employees and executives with a superior user experience while maintaining their existing desktop, files and settings. The service allows administrators to choose to manage all components in their own datacenter or use Citrix Operate space Cloud to move virtual desktop infrastructure (VDI) and virtual app administration to the cloud.
Citrix Systems, Inc. provides virtualization, mobility administration, networking, and Software as a Service solutions worldwide. The company’s Enterprise and Service Provider division offers XenMobile Enterprise, a solution to manage mobile devices, apps, and data; XenDesktop, a desktop virtualization system that gives customers the flexibility to deliver desktops and applications as cloud services; Citrix XenApp that allows Windows applications to be delivered as cloud services to Android and iOS mobile devices, Macs, PCs, and thin clients; and Citrix Operatespace Suite, a business mobility solution that delivers the user experience for any app or desktop.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
